The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Pasithea Therapeutics Corp. insider acquisitions

Company CIK 0001841330 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
KTTA · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.STEINMAN LAWRENCESTEINMAN LAWRENCESchneiderman Daniel HSchneiderman Daniel HMarques TiagoMarques TiagoDumesnil SimonDumesnil SimonLeahy EmerLeahy EmerNovak Alfred JNovak Alfred JSTEINMAN LAWRENCE · November 28, 2025 · Purchase · Common StockSchneiderman Daniel H · November 28, 2025 · Stock award · Common StockMarques Tiago · November 28, 2025 · Purchase · Common StockDumesnil Simon · November 28, 2025 · Purchase · Common StockLeahy Emer · November 28, 2025 · Stock award · Common StockSTEINMAN LAWRENCE · October 24, 2025 · Stock award · Stock Option (right to buy)Schneiderman Daniel H · October 24, 2025 · Stock award · Stock Option (right to buy)Novak Alfred J · October 24, 2025 · Stock award · Stock Option (right to buy)Marques Tiago · October 24, 2025 · Stock award · Stock Option (right to buy)Leahy Emer · October 24, 2025 · Stock award · Stock Option (right to buy)Dumesnil Simon · October 24, 2025 · Stock award · Stock Option (right to buy)Oct 24, 2025Nov 28, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

11 dated transactions · 6 of 6 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 28, 2025Pasithea Therapeutics Corp.Common StockSTEINMAN LAWRENCEPurchase
Nov 28, 2025Pasithea Therapeutics Corp.Common StockSchneiderman Daniel HStock award
Nov 28, 2025Pasithea Therapeutics Corp.Common StockMarques TiagoPurchase
Nov 28, 2025Pasithea Therapeutics Corp.Common StockDumesnil SimonPurchase
Nov 28, 2025Pasithea Therapeutics Corp.Common StockLeahy EmerStock award
Oct 24, 2025Pasithea Therapeutics Corp.Stock Option (right to buy)STEINMAN LAWRENCEStock award
Oct 24, 2025Pasithea Therapeutics Corp.Stock Option (right to buy)Schneiderman Daniel HStock award
Oct 24, 2025Pasithea Therapeutics Corp.Stock Option (right to buy)Novak Alfred JStock award
Oct 24, 2025Pasithea Therapeutics Corp.Stock Option (right to buy)Marques TiagoStock award
Oct 24, 2025Pasithea Therapeutics Corp.Stock Option (right to buy)Leahy EmerStock award
Oct 24, 2025Pasithea Therapeutics Corp.Stock Option (right to buy)Dumesnil SimonStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

KTTA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PurchaseCommon StockNon-derivative security · Code P133,3330.75Value: 99,999.75Currency not specifiedView ↗
Trade:
Schneiderman Daniel HChief Financial Officer
Stock awardCommon StockNon-derivative security · Code A26,6670.75Value: 20,000.25Currency not specifiedView ↗
Trade:
Marques TiagoChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P33,3330.75Value: 24,999.75Currency not specifiedView ↗
Trade: PurchaseCommon StockNon-derivative security · Code P33,3330.75Value: 24,999.75Currency not specifiedView ↗
Trade:
Leahy EmerDirector
Stock awardCommon StockNon-derivative security · Code A33,3330.75Value: 24,999.75Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A242,9130Value: 0Currency not specifiedView ↗
Trade:
Schneiderman Daniel HChief Financial Officer
Stock awardStock Option (right to buy)Derivative security · Code A317,2660Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A42,9130Value: 0Currency not specifiedView ↗
Trade:
Marques TiagoChief Executive Officer · Director
Stock awardStock Option (right to buy)Derivative security · Code A493,3410Value: 0Currency not specifiedView ↗
Trade:
Leahy EmerDirector
Stock awardStock Option (right to buy)Derivative security · Code A42,9130Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A42,9130Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →